title: Trypanosoma cruzi: effect of immunization on the risk of vector-delivered infection in guinea pigs.
abstract: The protective effect of experimental immunization was studied in guinea pigs exposed to vectorial infection by Trypanosoma cruzi. Immunized animals received an inoculum of live-attenuated T. cruzi epimastigotes into a granuloma previously induced by Freund's complete adjuvant in the hind footpad. Seven days later, a delayed-type hypersensitivity reaction was triggered by reinjection of the parasites in the front footpad. The animals were then placed in Triatoma infestans-colonized corrals and exposed to vectorial T. cruzi transmission of the parasite for up to 200 days. The effectiveness of this immunizing protocol was controlled in terms of the number of bites necessary for infection (NBNI) in immunized as compared with control animals. Periodic entomological census allowed for the determination of vector biting and infection rates and the calculation of NBNI. Although this measurement was quite variable between yards, an overall average of 4,973 bites was enough to infect a control guinea pig in 4 separate experiments. The corresponding figure for the experimental group was 21,307 bites, implying that immunized animals could resist a 4.28-fold increase (range: 1.99-8.32) in the number of vector bites before becoming infected.
authors.affiliation: Laboratorio de Patología Experimental, Facultad de Ciencias de la Salud, Universidad Nacional de Salta, Argentina.
authors.forename: M A
authors.initials: MA
authors.lastname: Basombrío
authors.forename: J R
authors.initials: JR
authors.lastname: Nasser
authors.forename: M A
authors.initials: MA
authors.lastname: Segura
authors.forename: L E
authors.initials: LE
authors.lastname: Gomez
mesh_terms: D000818:Animals; D014355:Chagas Disease / Q000276:immunology / Q000469:parasitology / Q000517:prevention & control*; D006168:Guinea Pigs; D007113:Immunity, Innate; D007303:Insect Vectors / Q000276:immunology*; D016052:Protozoan Vaccines / Q000276:immunology*; D011897:Random Allocation; D012307:Risk Factors; D014224:Triatoma / Q000276:immunology*; D014349:Trypanosoma cruzi / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000276:immunology
chemical_list: D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated